How to best deliver ‘4 pillars’ of treatment in T2D and CKD

Pharma funding: which specialties accept the most payments?

Antivenom delay led to renal failure after tiger snake bite

Australian trial will assess less intensive corticosteroids in paediatric nephrotic syndrome

Why the pathology bulk-billing campaign is more about driving industry profits than saving you money

Transplant surgeon banned for relationship with kidney recipient

MORE NEWS

more news